InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Jean-Marie Lefèvre, Chairman of the Board. Insider active across 1 companies, notably MAAT PHARMA. In total, 1 reports have been published. The latest transaction was filed on 17 February 2023 — Souscription. Regulator: AMF. The full history is accessible without signup.
Declarations1 total
€2m250,000 shares@ €8.00100.0% of flow
ActionEuronext Paris
2023DD885900·
1 of 1 declaration
About Jean-Marie Lefèvre
Jean-Marie Lefèvre is the Chairman of the Board at Maat Pharma. In this role, he oversees the activities of the board and ensures the good governance of the company. His experience in the pharmaceutical sector allows him to guide the company in its strategic decisions and ensure compliance with current regulations. He plays a key role in the future direction of Maat Pharma.
